Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6765)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2015 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheung BB. Combination therapies improve the anticancer activities of retinoids in neuroblastoma. World J Clin Oncol 2015; 6(6): 212-215 [PMID: 26677433 DOI: 10.5306/wjco.v6.i6.212] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v6/i6/212.htm |
| Number | Citing Articles |
| 1 |
Viviane Rösner Almeida, Igor Araujo Vieira, Marienela Buendia, André Tesainer Brunetto, Lauro J. Gregianin, Algemir Lunardi Brunetto, Fábio Klamt, Caroline Brunetto de Farias, Ana Lucia Abujamra, Patrícia Luciana da Costa Lopez, Rafael Roesler. Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells. Molecular Neurobiology 2017; 54(10): 7610 doi: 10.1007/s12035-016-0250-3
|
| 2 |
Olaia Aurtenetxe, Laura Zaldumbide, Asier Erramuzpe, Ricardo López, José I. López, Jesús M. Cortés, Rafael Pulido, Caroline E. Nunes-Xavier. DUSP5 expression associates with poor prognosis in human neuroblastoma. Experimental and Molecular Pathology 2018; 105(3): 272 doi: 10.1016/j.yexmp.2018.08.008
|
| 3 |
Jiayu Zhu, Huihui Wang, Feng Chen, Jingqi Fu, Yuanyuan Xu, Yongyong Hou, Henry H. Kou, Cheng Zhai, M. Bud Nelson, Qiang Zhang, Melvin E. Andersen, Jingbo Pi. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radical Biology and Medicine 2016; 99: 544 doi: 10.1016/j.freeradbiomed.2016.09.010
|
| 4 |
David J. Duffy, Aleksandar Krstic, Melinda Halasz, Thomas Schwarzl, Anja Konietzny, Kristiina Iljin, Desmond G. Higgins, Walter Kolch. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance. Genome Medicine 2017; 9(1) doi: 10.1186/s13073-017-0407-3
|
| 5 |
|
| 6 |
Maria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, Federica Rinaldi, Carlotta Marianecci, Isabella Screpanti, Saula Checquolo, Maria Carafa. Current Trends in ATRA Delivery for Cancer Therapy. Pharmaceutics 2020; 12(8): 707 doi: 10.3390/pharmaceutics12080707
|
| 7 |
Ke Wang, Ye Li, Linlin Wang. Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03426-8
|
| 8 |
Hui-Ching Chuang, Hung-Yu Lin, Pei-Lin Liao, Chao-Cheng Huang, Li-Ling Lin, Wen-Ming Hsu, Jiin-Haur Chuang. Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response. Laboratory Investigation 2020; 100(4): 606 doi: 10.1038/s41374-019-0356-0
|
| 9 |
|
| 10 |
Nerea Mosquera, Angela Rodriguez-Trillo, Francisco J. Blanco, Antonio Mera-Varela, Antonio Gonzalez, Carmen Conde. All-Trans Retinoic Acid Inhibits Migration and Invasiveness of Rheumatoid Fibroblast-Like Synoviocytes. The Journal of Pharmacology and Experimental Therapeutics 2020; 372(2): 185 doi: 10.1124/jpet.119.261370
|
| 11 |
Raoud Marayati, Laura V. Bownes, Colin H. Quinn, Nikita Wadhwani, Adele P. Williams, Hooper R. Markert, Venkatram Atigadda, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Elizabeth A. Beierle. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts. Journal of Pediatric Surgery 2021; 56(6): 1165 doi: 10.1016/j.jpedsurg.2021.02.041
|
| 12 |
Lourdes Sainero-Alcolado, Muhammad Mushtaq, Judit Liaño-Pons, Aida Rodriguez-Garcia, Ye Yuan, Tong Liu, María Victoria Ruiz-Pérez, Susanne Schlisio, Oscar Bedoya-Reina, Marie Arsenian-Henriksson. Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02399-x
|
| 13 |
Isabella Orienti, Giovanna Farruggia, Ferro Nguyen, Peng Guan, Natalia Calonghi, Venkatadri Kolla, Michael Chorny, Garrett M. Brodeur. <p>Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an <em>MYCN</em> Amplified Neuroblastoma Tumor</p>. International Journal of Nanomedicine 2020; : 6873 doi: 10.2147/IJN.S262032
|
| 14 |
Caroline E. Nunes-Xavier, Olaia Aurtenetxe, Laura Zaldumbide, Ricardo López-Almaraz, Asier Erramuzpe, Jesús M. Cortés, José I. López, Rafael Pulido. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma. Diagnostic Pathology 2019; 14(1) doi: 10.1186/s13000-019-0919-9
|
| 15 |
Raoud Marayati, Laura V. Bownes, Laura L. Stafman, Adele P. Williams, Colin H. Quinn, Venkatram Atigadda, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Elizabeth A. Beierle. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts. Translational Oncology 2021; 14(1): 100893 doi: 10.1016/j.tranon.2020.100893
|